These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 35612215)

  • 21. Efficacy and safety of a biosimilar recombinant human growth hormone (r-hGH Cristalia) compared with reference r-hGH in children with growth hormone deficiency (CERES study): A randomized, multicentric, investigator-blind, phase 3 trial.
    Czepielewski MA; Garret Q; Vencio SAC; Rassi N; Felicio JS; Faria MS; Senn CCP; Bronstein MD; Cerqueira MJAG; Neves ACL; Sgarbi JA; Spinola-Castro AM; Cunha MPR; Bandeira F; Toffoletto O; Afiune J; Baradelli R; Rodrigues DG; Scharf M
    Growth Horm IGF Res; 2019; 48-49():29-35. PubMed ID: 31493626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The growzen™ buddy smartphone app to improve adherence in patients receiving recombinant human growth hormone therapy: a retrospective observational study in Argentina.
    van Dommelen P; Arnaud L; Assefi AR; Crespo ML; Debicki M; Michelis F; Koledova E
    Front Endocrinol (Lausanne); 2024; 15():1372716. PubMed ID: 39015178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adherence to growth hormone (GH) therapy in naïve to treatment GH-deficient children: data of the Italian Cohort from the Easypod Connect Observational Study (ECOS).
    Centonze C; Guzzetti C; Orlando G; Loche S;
    J Endocrinol Invest; 2019 Oct; 42(10):1241-1244. PubMed ID: 30968283
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improved adherence and growth outcomes with jet-delivered growth hormone.
    Michaelidou M; Whitten S; Bajaj P; Knight A; Spoudeas HA
    J Pediatr Endocrinol Metab; 2019 Mar; 32(3):207-213. PubMed ID: 30844762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Observations of nonadherence to recombinant human growth hormone therapy in clinical practice.
    Haverkamp F; Johansson L; Dumas H; Langham S; Tauber M; Veimo D; Chiarelli F
    Clin Ther; 2008 Feb; 30(2):307-16. PubMed ID: 18343269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PREVALENCE AND CORRELATES OF ADHERENCE IN CHILDREN AND ADOLESCENTS TREATED WITH GROWTH HORMONE: A MULTICENTER ITALIAN STUDY.
    Bagnasco F; Di Iorgi N; Roveda A; Gallizia A; Haupt R; Maghnie M;
    Endocr Pract; 2017 Aug; 23(8):929-941. PubMed ID: 28614005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Connected health for growth hormone treatment research and clinical practice: learnings from different sources of real-world evidence (RWE)-large electronically collected datasets, surveillance studies and individual patients' cases.
    Boman N; Fernandez-Luque L; Koledova E; Kause M; Lapatto R
    BMC Med Inform Decis Mak; 2021 Apr; 21(1):136. PubMed ID: 33902570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variability in adherence to rhGH treatment: Socioeconomic causes and effect on children's growth.
    De Pedro S; Murillo M; Salinas I; Granada ML; Martinez M; Puig-Domingo M; Andreu A; Bel J
    Growth Horm IGF Res; 2016 Feb; 26():32-5. PubMed ID: 26774403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patients' Perception of the Use of the EasyPod™ Growth Hormone Injector Device and Impact on Injection Adherence: A Multi-Center Regional Study.
    Deeb A; Al Yaarubi S; Abbas BB; Al Jubeh J; Chaturvedi D; Al Hassani N; Mutair A; Al Masri N; Al Sanad Y; Al Shidhani A; Mahmoud NS; Alherbish A; Savage MO
    Front Pediatr; 2022; 10():839278. PubMed ID: 35295698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digital technologies to improve the precision of paediatric growth disorder diagnosis and management.
    Dunkel L; Fernandez-Luque L; Loche S; Savage MO
    Growth Horm IGF Res; 2021 Aug; 59():101408. PubMed ID: 34102547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adherence and long-term outcomes of growth hormone therapy with easypod™ in pediatric subjects: Spanish ECOS study.
    Rodríguez Arnao MD; Rodríguez Sánchez A; Díez López I; Ramírez Fernández J; Bermúdez de la Vega JA; Yeste Fernández D; Chueca Guindulain M; Corripio Collado R; Pérez Sánchez J; Fernández González A
    Endocr Connect; 2019 Sep; 8(9):1240-1249. PubMed ID: 31484160
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adherence to r-hGH Therapy in Pediatric Growth Hormone Deficiency: Current Perspectives on How Patient-Generated Data Will Transform r-hGH Treatment Towards Integrated Care.
    Savage MO; Fernandez-Luque L; Graham S; van Dommelen P; Araujo M; de Arriba A; Koledova E
    Patient Prefer Adherence; 2022; 16():1663-1671. PubMed ID: 35846871
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-administration of Recombinant Human Growth Hormone with an Electronic Device: Clinical, Economic and Management Benefits of Objective Adherence Monitoring.
    Saz-Parkinson Z; Granados Alonso MDS; Bouza C; Poveda Andrés JL; Amate JM
    J Health Econ Outcomes Res; 2014; 1(3):296-307. PubMed ID: 37662880
    [No Abstract]   [Full Text] [Related]  

  • 34. Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study.
    Gao J; Arden M; Hoo ZH; Wildman M
    BMC Health Serv Res; 2019 Jun; 19(1):420. PubMed ID: 31234848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Six-month, prospective, longitudinal, open-label caffeine and dextromethorphan phenotyping study in children with growth hormone deficiency receiving recombinant human growth hormone replacement.
    Kennedy MJ; Davis DA; Smith N; Gaedigk A; Pearce RE; Kearns GL
    Clin Ther; 2008 Sep; 30(9):1687-99. PubMed ID: 18840375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced Cochlear Implant Performance After the Use of Growth Hormone With Regain of Function After Cessation of Growth Hormone Therapy.
    Lafer MP; Green JE; Heman-Ackah SE; Roland JT; Waltzman SB
    Otol Neurotol; 2015 Jul; 36(6):1006-9. PubMed ID: 25730449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Perception of Adherence to Daily Human Growth Hormone Treatments Among Pediatric and Adolescent Patients in Japan: A Cross-Sectional Survey of Physicians and Caregivers.
    Akazawa M; Shima D; Sato T; Shoji E; LoPresti M; Nishi R
    Patient Prefer Adherence; 2022; 16():3081-3094. PubMed ID: 36387049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday use.
    Dahlgren J; Veimo D; Johansson L; Bech I
    Curr Med Res Opin; 2007 Jul; 23(7):1649-55. PubMed ID: 17559757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new pen device for injection of recombinant human growth hormone: a convenience, functionality and usability evaluation study.
    Sauer M; Abbotts C
    Patient Prefer Adherence; 2018; 12():27-34. PubMed ID: 29343946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development and Psychometric Evaluation of the Life Interference Questionnaire for Growth Hormone Deficiency (LIQ-GHD) to Assess Growth Hormone Injection Burden in Children and Adults.
    Turner-Bowker DM; Yaworsky A; Palladino A; Lamoureux RE; Kelly M; Love E; Pleil AM; Shields A; Loftus J
    Patient; 2020 Jun; 13(3):289-306. PubMed ID: 31956960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.